Support our Foundation of Myology project
1704 news items
Preliminary results of FIREFISH, a trial evaluating ridisplam in type 1 SMA
On 11/05/2020
The primary endpoint of the second part of the FIREFISH clinical trial has been met. This is an announcement by Roche and PTC Therapeutics, the…
Drug-induced myopathies: beware of the toxic effects of immune control point inhibitors
On 03/03/2020
Drug-induced myopathy is among the most common causes of muscle disease. An association has recently been described between programmed death-1 (PD-1)/PD-1 ligand (PD-L1) inhibitors and…
Release of the 77th newsletter from the Institute
On 31/01/2020
The Institute of Myology wishes you all the best for 2020 Welcome to the first issue of our newsletter for the new year! …
Expanding the phenotype of filamin-C-related myofibrillar myopathy
On 07/05/2019
A tean of Danish researhers reports three patients with a rare filamin C myofibrillar myopathy. They present with atypical symptoms that expand the phenotype of…
